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Two natural variants of the lantibiotic nisin that are produced by Lactococcus lactis are known. They have
a similar structure but differ in a single amino acid residue at position 27: histidine in nisin A and asparagine
in nisin Z (J. W. M. Mulders, I. J. Boerrigter, H. S. Rollema, R. J. Siezen, and W. M. de Vos, Eur. J.
Biochem. 201:581-584, 1991). The nisin variants were purified to apparent homogeneity, and their biological
activities were compared. Identical MICs ofnisin A and nisin Z were found with all tested indicator strains of
six different species of gram-positive bacteria. However, at concentrations above the MICs, with nisin Z the
inhibition zones obtained in agar diffusion assays were invariably larger than those obtained with nisin A. This
was observed with all tested indicator strains. These results suggest that nisin Z has better diffusion properties
than nisin A in agar. The distribution of the nisin variants in various lactococcal strains was determined by
amplification of the nisin structural gene by polymerase chain reaction followed by direct sequencing of the
amplification product. In this way, it was established that the nisZ gene for nisin Z production is widely
distributed, having been found in 14 of the 26 L. lactis strains analyzed.
Various gram-positive bacteria produce small peptides
with antimicrobial activity that share the presence of the
unusual amino acids lanthionine and P-methyllanthionine
and hence are termed lantibiotics (13, 27). Several of these
lantibiotics have been characterized at the protein and gene
levels, including subtilin, made by Bacillus subtilis (2);
epidermin (27) and Pep5 (15), which are synthesized by
Staphylococcus spp.; and nisin, produced by Lactococcus
lactis (4, 9). Comparison of the protein and gene sequences
of the lantibiotics has shown that they are ribosomally
synthesized as prepeptides containing an unusual and struc-
turally homologous leader sequence that may be involved in
posttranslational modification processes (4, 13, 27). Evi-
dence of the existence of some of these modification reac-
tions has recently been provided by the isolation of intracel-
lular processing intermediates of Pep5 (30).
Nisin is a heat-stable peptide that was first described to be
produced by a single strain of group N streptococci, now
known as lactococci (17). It is widely used as a natural food
preservative since it shows antimicrobial activity against
various gram-positive bacteria, including strains of Clostrid-
ium, Listeria, and Bacillus spp. and most lactic acid bacteria
(12). Initial biochemical studies showed that nisin isolated
from a single producer strain consists of a mixture ofclosely
related peptides with different antimicrobial activities (3).
The structure of the 34-residue main component with the
highest activity, nisin A, has been determined (9). Recent
genetic studies have shown that a single structural gene for
nisin production (designated nisA [14]) is present in four
different nisin-producing L. lactis strains (4, 7, 14, 19) and is
located on large conjugative transposons in several strains
(11, 19). The deduced sequence of the 34-amino-acid struc-
tural region of the nisin precursor confirms the previously
determined structure of nisin A (9), substantiates the postu-
lated posttranslational modification reactions (13), and indi-
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cates that the initially identified forms of nisin may be
attributed to degradation ofmaturated nisin (6) or to different
degrees of posttranslational modification.
In the course of screening naturally occurring nisin over-
producers, we identified L. lactis NIZO 22186 which had
been isolated from a dairy product. This strain produced
high levels of an antimicrobial activity similar but not
identical to that of nisin. Subsequent biochemical and ge-
netic characterization showed that strain NIZO 22186 pro-
duces a natural nisin variant encoded by the nisZ gene (18).
The nisA and nisZ genes differ in a single nucleotide substi-
tution in the structural region. As a consequence, the nisZ-
encoded lantibiotic, designated nisin Z, contains an aspar-
agine at position 27 instead of a histidine as in nisin A (18).
In this report, we compare relevant physicochemical and
biological properties ofnisin Zwith those ofits variant, nisin
A, and show that the nisZ gene is widely distributed in
naturally occurring nisin-producing L. lactis strains.
(A preliminary account of some of these results was
reported at the First International Workshop on Lantibiot-
ics, 1991, Bad Honnef, Germany.)
MATERIALS AND METHODS
Strains, media, and bioassays of nisin analogs. L. lactis
strains screened for the production of lantibiotics and their
origins are listed in Table 1. L. lactis cells were routinely
grown at 30°C in media based on M17 medium (Oxoid Ltd.,
Basingstoke, England) supplemented with 0.5% lactose,
glucose, or sucrose when appropriate. For production of
lantibiotics, L. lactis strains were grown as described previ-
ously (18).Micrococcusflavus DSM 1719 (obtained from the
German Collection of Microorganisms, Braunschweig, Ger-
many) was grown under aerobic conditions in nutrient broth
(Difco Laboratories, Detroit, Mich.). The following strains
were obtained from the Netherlands Institute for Dairy
Research (NIZO) culture collection and handled as indi-
cated: Bacillus cereus (strains P7 and C5) and Listeria
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TABLE 1. L. lactis strains used in this study, their origin, and
the presence of nisA or nisZ genes as deduced from
sequence analysis of PCR-amplified nis genes
Strain Type of Source (reference)a nisin gene
NIZO R5 nisA NIZO collection (19)
INRA 1 nisA G. Limsowtin, INRA
INRA 2 nisA G. Limsowtin, INRA
INRA 3 nisA G. Limsowtin, INRA
INRA 4 nisA G. Limsowtin, INRA
INRA 5 nisA G. Limsowtin, INRA
INRA 6 nisA G. Limsowtin, INRA
NP4G nisA L. Topisirovic, Institute for Molec-
ular Genetics, Belgrade,
Yugoslavia
NZI nisA M. Nuti, University of Padua, Padua,
Italy
NCDO 2111 nisA NCDO
Si nisA J. Bardowski, INRA
ILC13 nisA G. Giraffa, ILC
NIZO 22186 nisZ NIZO collection (18)
NIZO N9 nisZ NIZO collection
ATCC 7962 nisZ Obtained as NCDO 2054 from NCDO
NCDO 2118 nisZ NCDO
NCDO 2597 nisZ Obtained as LMG 8514 from B. Pot,
LMG Culture Collection, Ghent,
Belgium
NCDO 2091 nisZ Obtained as LMG 8526 from B. Pot,
LMG
NCK400 nisZ T. R. Klaenhammer, NCSU (10)
LJN80 nisZ T. R. Klaenhammer, NCSU (10)
ILC1l nisZ G. Giraffa, ILC
ILC19 nisZ G. Giraffa, ILC
ILC126 nisZ G. Giraffa, ILC
ILCSL5 nisZ G. Giraffa, ILC
ILCSL20 nisZ G. Giraffa, ILC
I01 nisZ A. Ishizaki, Kyushu University,
Higashi-ku, Japan
a INRA, Institut National de Recherche Agronomique, Jouy en Josas,
France; NCDO, National Collection of Dairy Organisms; ILC, Instituto
Sperimentale Lattiero-Caseario, Lodi-Milan, Italy; NCSU, North Carolina
State University.
monocytogenes (strains 13 and669), grown inTrypticase soy
broth (Difco Laboratories) at 30°C under aerobic and anaer-
obic conditions, respectively; Streptococcus thermophilus
Rs, grown in a medium containing, per liter, 10g oftryptone,
3 g of meat extract, 5 g of yeast extract (all from Difco
Laboratories), 2 g ofdipotassium monohydrogen phosphate,
40 ml of tomato juice, and 1 ml of Tween 80 (E. Merck AG,
Darmstadt, Germany), pH 6.8, at 37°C; Clostridium tyrobu-
tyricum BZ15, grown under anaerobic conditions in recon-
stituted Clostridium medium (E. Merck AG) at 30°C; andL.
lactis subsp. cremoris BA3, grown in lactose-M17 medium at
300C.
Antimicrobial activity was routinely determined by using
an agar diffusion bioassay (28), with M. flavus or one of the
other above-mentioned gram-positive bacteria as the indica-
tor strain. Plates were prepared by adding a 0.1% inoculum
of an exponentially growing culture of the indicator strain to
25 ml of growth medium solidified with 1.5% agar. After
solidification in rectangular plates, wells (6.0 mm in diame-
ter) were made with a sterile stainless-steel cork bore and
filled with 40 ,ul of test solution. After incubation at 30°C (25
h forM. flavus), the radii of the halos were determined with
a Nikon Profile Projector (model C; Nippon Kogaku, Tokyo,
Japan). To determine the MICs oflantibiotics, exponentially
growing cultures were diluted 100-fold in media containing
no (control) or different concentrations of purified lantibiot-
ics and further incubated until control cultures were grown
to saturation. The MIC was taken as the lowest concentra-
tion of lantibiotic that resulted in the absence of detectable
growth. Cross-immunity was determined by following the
growth ofL. lactis NIZO R5 and NIZO 22186 in lactose-M17
containing different amounts of purified lantibiotics.
DNA manipulation, PCR, and DNA sequencing. L. lactis
total DNA was isolated by lysing protoplasts (29) by the
addition of 1% sodium dodecyl sulfate (SDS) and deprotein-
ized by subsequent extractions with phenol and chloroform,
which were followed by repeated ethanol precipitations (24).
DNA was dissolved in 10 mM Tris HCl (pH 8.0)-i mM
EDTA, and approximately 100 ng was subjected to amplifi-
cation by the polymerase chain reaction (PCR) (23) in a total
volume of 50 pl containing 1 U of Taq polymerase (GIBCO-
Bethesda Research Laboratories, Gaithersburg, Md.), 50
mM NaCl, 10 mM Tris HCl (pH 8.8), 2 mM MgCl2, 10 ,ug of
gelatin, 0.2 mM each deoxynucleoside triphosphate, 10 pmol
of each primer, and 2.5 ,ll of stabilizer (1% N-1; GIBCO-
Bethesda Research Laboratories) and coveredwith 100 ,ul of
light mineral oil. The PCR amplifications were performed in
30 cycles, using a Thermocycler (Bio-Med, Amstelstad, The
Netherlands); each cycle consisted of a denaturing step at
93°C for 2 min, a primer annealing step at 54°C for 1 min, and
an extension step at 72°C for 1.5 min. The amplified DNA
yielded a single band upon agarose gel electrophoresis (24)
that was recovered with a Gene-Clean kit (Bio 101, La Jolla,
Calif.). Sequencing of the thus purified DNA was performed
by the dideoxy chain termination method (25), using the
optimal conditions described byCasanova et al. (5), with the
additional modification that all buffers and solutions con-
tained 0.5% Nonidet P-40 (GIBCO-Bethesda Research Lab-
oratories). Oligonucleotide primers used for PCR and for
sequencing were 5'-CGCGAGCATAATAAACGGCT-3' and
5'-GGATAGTATCCATGTCTGAAC-3', which are comple-
mentary to regions 80 bp upstream and 29 bp downstream of
the coding regions of the nisA and nisZ genes, respectively
(18). Oligonucleotides were synthesized on a Cyclone DNA
synthesizer (Biosearch, San Rafael, Calif.).
Purification and quantification of lantibiotics. Nisin vari-
ants were purified from culture supernatants of L. lactis
NIZO R5 and NIZO 22186 grown for 16 h at 30°C as
described before (19). Purification ofthe lantibiotics by using
hydrophobic interaction chromatography on Fractogel TSK
butyl 650-S (E. Merck AG), ultrafiltration, preparative re-
versed-phase high-performance liquid chromatography
(HPLC), and freeze-drying was performed as described
elsewhere (18). Purified lantibiotics were dissolved in 0.05%
acetic acid, and absolute amounts were calculated from the
A220, using an extinction coefficient of 21.2 deduced from
analyzing absorbance determinations and 1H-nuclear mag-
netic resonance spectroscopy (21). In addition, the quantity
and quality of the lantibiotic samples were determined by
analytical reversed-phase HPLC performed on a Hi-Pore
RP-318 column (250 by 4.6 mm; Bio-Rad Laboratories,
Richmond, Calif.), using a linear gradient of 23 to 28% buffer
B (90% aqueous acetonitrile, 0.07% trifluoroacetic acid) in
buffer A (10% aqueous acetonitrile, 0.1% trifluoroacetic
acid) for 50minwith a flow rate of 1 ml/min. Absorbance was
monitored at 220 nm.
Gel electrophoresis and detection of nisin analogs. Tricine-
SDS gel electrophoresis (26) of lantibiotics and low-molecu-
lar-weight standards (Bio-Rad Laboratories) on SDS-20%
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FIG. 3. Relation between the radius of the inhibition zone and
the concentration ofpurified nisin Z (Z) or nisin A (A) in a standard
agar diffusion assaywithM. flavus as the indicator (28). Values have
been derived from three independent experiments, and the standard
error is indicated by the bars.
the same procedure. Significant differences between nisin A
and nisin Z were obtained in dose-response curves that
relate the radius of the inhibition zones to the concentration
of added lantibiotic (Fig. 3). These differences include both
the shape and the slope of the dose-response curves. With
nisin Z there was a nearly linear relation between the radius
ofthe inhibition zone and the logarithm of the concentration
of lantibiotic up to approximately 10 ,ug/ml. In contrast, this
linear relation was absent with nisin A above 1 ,ug/ml. The
dose-response curves converged at a concentration of ap-
proximately 0.03 ,ug of lantibiotic per ml, where a similar
inhibition zone was found.
Moreover, it appeared that the inhibition zones obtained
with nisin Z were significantly larger than those obtained
with nisin A at concentrations above 0.1 p,g/ml, with a
maximal difference at approximately 100 ,ug/ml. Careful
inspection of the inhibition zones revealed that the bound-
aries of the halos obtained with nisin Z were less sharp than
those of the halos obtained with nisin A (data not shown).
This was most noticeable below 0.1 ,g of lantibiotic per ml
and was also observed when nisin Z was assayed with other
nisin-sensitive bacteria (see below).
To study possible differences in specific antimicrobial
activity, the MICs of both lantibiotics were determined in
liquid cultures of M. flavus. The MICs appeared to be
identical (0.015 ,ug/ml) for both nisin variants (Table 2) and
were close to the concentrations that showed similar-sized
inhibition zones in the agar diffusion test. These results
demonstrate that there is no difference in specific activities
of nisin A and nisin Z against M. flavus.
Spectrum of antimicrobial activity and cross-immunity. To
compare the spectrum of antimicrobial activity of nisin Z
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FIG. 1. Analytical reversed-phase HPLC of purified nisin A and
nisin Z.
polyacrylamide gels was performed with unheated samples
as described before (18).
RESULTS
Purification of nisin variants and differences in separation.
Nisin Z produced byL. lactis NIZO 22186 (18) was purified
and compared with purified nisin A isolated from L. lactis
NIZO R5 known to contain the nisA gene (19). Analytical
reversed-phase HPLC (Fig. 1) showed that both variants
were >97% pure. In addition, this chromatogram showed
that the nisin variants showed clear differences in elution
times, with nisin Z eluting approximately 2 min later than
nisin A. The purity of the lantibiotics was also evident from
Tricine-SDS gel electrophoresis that showed single bands
with identical apparent molecular weights of 3,500 (Fig. 2).
Differences in antimicrobial activities ofnisin Aand nisin Z.
Initial experiments showed that the undiluted culture super-
natant of NIZO 22186 resulted in much larger inhibition
zones than that of NIZO R5 in a standard agar diffusion
bioassay (28) with M. flavus as an indicator (data not
shown). Therefore, the antimicrobial activities of the puri-
fied and standardized nisin variants were compared, using
18.4 '
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3.0- 10-
FIG. 2. SDS-polyacrylamide gel electrophoresis (26) of purified
nisin A and nisin Z. Identical amounts (5 ,ug) of nisin Z (lane 1) and
nisin A (lane 2) were applied, and the gels were stained with
Coomassie blue. Molecular weight markers (103) are indicated on
the left.
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TABLE 2. Inhibition zones and MICs obtained for nisin A and
nisin Z, using different nisin-sensitive indicator
strains and nisin producers
Radius of MIC
inhibition zone (p.g/ml) Strain (mm)a
Nisin A Nisin Z Nisin A Nisin Z
M. flavus DSM 1719 6.2 6.7 0.015 0.015
S. thermophilus Rs 4.0 4.5 0.030 0.030
B. cereus P7 2.4 3.2 0.3 0.3
B. cereus C5 4.2 5.3 0.1 0.1
Listena monocytogenes 13 1.5 2.0 1 1
Listena monocytogenes 669 3.0 3.5 0.2 0.2
C. tyrobutyricum BZ15 4.7 5.4 0.05 0.05
L. lactis subsp. cremons BA3 3.6 4.2 0.05 0.05
L. lactis subsp. lactis NIZO R5 0 0 50 50
L. lactis subsp. lactis NIZO 22186 0 0 50 50
a Values were obtained with identical concentrations (4p.g/ml) oflantibiotic
in the agar diffusion test.
with that of nisin A, eight strains belonging to six known
nisin-sensitive species were used as indicator organisms in
agar diffusion tests and in liquid cultures to determine MICs
(Table 2). In all cases, it appeared that the inhibition zones
obtained with high concentrations ofnisin Zwere larger than
those of nisin A. However, all strains that were sensitive to
nisin A were also sensitive to nisin Z, and vice versa. The
sizes ofthe inhibition zones varied considerably between the
different indicator strains and were inversely related to the
MICs. Interestingly, the MICs of nisin A were identical to
those of nisin Z for all strains, indicating that there is no
difference in the specific antimicrobial activities of the lanti-
biotic variants against these hosts.
When the lantibiotic producer strains NIZO R5 and NIZO
22186 were used in this assay, no inhibition zones were
observed up to 100 ,ug ofnisin A or nisin Z per ml, indicating
that producer strains are immune to their own products
(Table 2). In addition, these producer strains showed similar
immunity to either of the lantibiotics in liquid medium (MIC
of approximately 50 ,ug/ml), indicating cross-immunity to
nisin A and nisin Z.
Distribution ofnisZ and nisA genes in L. lactis strains. To
determine whether NIZO 22186 was the only strain that
produced nisin Z, the distribution of the nisZ gene was
determined in 26 sucrose-fermenting and putatively nisin-
producing strains ofL. lactis from a variety of national and
private collections as well as NIZO isolates (Table 1). Total
DNAwas isolated from these strains, and the structural nisin
gene was amplified by PCR, resulting in a 0.35-kb DNA
fragment. The presence of nisA or nisZ genes was deter-
mined by direct sequencing of the PCR product. The results
(Table 1) show that nisZ genes are widespread in nature and
are present in a frequency (14 ofthe 26) similar to that ofthe
nisA genes in the tested strains. In all cases, a unique
sequence ladder was obtained, indicating that a single nis
gene species was present in the strains. In strain NCDO
2118, a small insertion of 16 bp was detected between
positions 180 and 181 (numbering as in reference 18), which
is located just downstream of the nisZ structural gene. This
insertion consists of a tandem duplication of the octanucle-
otide AACCAAAT present at positions 173 to 180. All other
sequences were as reported for the nisA or nisZ genes,
differing only in the nucleotide at position 148 (4, 18).
DISCUSSION
We describe the comparison and distribution of two nat-
urallyoccurring nisinvariants, nisin A and nisin Z (18). Nisin
A was the first lantibiotic to be described (9, 17), and its
structural gene (nisA) has been isolated from at least four
differentL. lactis strains (4, 7, 14, 19). Nisin Z is encoded by
the nisZ gene and has recently been described in strain
NIZO 22186 (18). The nisA and nisZ genes differ in a single
nucleotide substitution at position 148 (18), resulting in the
substitution of the histidine at position 27 in nisin A by an
asparagine residue in nisin Z. It is shown here that this single
substitution is widely distributed and results in different
physicochemical, but not biological, properties of the nisin
variants that are relevant to their application.
The most prominent property associated with nisin Z-pro-
ducing L. lactis strains such as NIZO 22186 is the large size
of the inhibition zones obtained in agar diffusion assays with
undiluted culture supernatants, which is not observed to the
same extent with known nisin A producers. This suggests a
higher production level and/or a higher specific activity of
nisin Z than nisin A. Careful comparison of purified and
standardized nisin A and nisin Z preparations showed that,
at concentrations above approximately 0.1 ,ug/ml, nisin Z
produced significantly larger halos than the identical concen-
tration of nisin A (Fig. 3). This observation appeared to be
independent of the indicator organism (Table 2). In contrast,
at a low concentration (0.03 ,ug/ml), no difference in the
antimicrobial activities ofthe two variants could be detected
(Fig. 3). This observation is in agreement with the identical
MICs observed for nisin A and nisin Z with different
sensitive bacteria and the cross-immunity of the producer
strains (Table 2). These results indicate that there is no
difference between the nisin variants in specific antimicro-
bial activity against the tested strains. Amajor implication is
that the amino acid residue at position 27, being either
asparagine or histidine, does not affect the biological activity
of the variants and that the mode of action of nisin Z is
comparable to that of nisin A, which has been studied
extensively (8, 22).
The question arises, what determines the larger inhibition
zones obtained in agar diffusion tests with nisin Z in com-
parison with nisin A at concentrations above the MICs
(Table 2)? The formation of inhibition zones is affected by
properties of both the lantibiotic (e.g., solubility, stability,
aggregation behavior, and diffusion) and the indicator organ-
ism (e.g., growth rate, inactivation properties, and sensitiv-
ity). It is unlikely that the properties of the indicator organ-
ism are involved in the larger inhibition zones obtained with
nisin Z, since the only lantibiotic-specific property, i.e., the
sensitivity to nisin A and nisin Z, is identical for both
variants as deduced from the MIC determinations (Table 2).
This suggests that only the physicochemical properties of
nisin Z are contributing to the formation of the large inhibi-
tion zones. On the basis of the nature of the His27Asn
substitution in nisin Z, it is expected that nisin Z solubility is
higher than nisin A solubility at pH values above pH 6 (the
pK value of His) since the Asn side chain is more polar than
the uncharged His side chain. However, both nisin variants
have excellent and comparable solubility and stability at the
concentration (up to 100 ,ug/ml) and pH (below 7) used in the
bioassays (16, 21). This implies that a difference in the
diffusion rate is the factor that contributes to the larger
inhibition zones of nisin Z. This may be of practical signifi-
cance since many products to which nisin is applied (12) are
diffusion limited.
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The marked differences between the shape and slope of
the dose-response curves ofnisin A and nisin Z (Fig. 3) have
important implications for the accuracy of determining the
nisin content of commercial and laboratory preparations.
This is regularly done by comparing the inhibition zones of
the unknown sample and a standard nisin A sample in an
agar diffusion bioassay with Micrococcus luteus as the
indicator (1, 28). The nisin content is subsequently ex-
pressed as international (Reading) units (1, 28). Since nisin Z
shows much larger inhibition zones than nisin A at concen-
trations above approximately 0.1 ±g/ml (Fig. 3), it is not
possible to express nisin Z quantities in international units.
This indicates that the conventional method is only applica-
ble to samples known to contain only nisin A.
To study the distribution of nisin A and nisin Z producers,
a large number of different L. lactis strains were analyzed at
the gene level by PCR amplification of the nis gene and
subsequent sequence analysis of the amplified DNA. This
approach eliminated possible PCR errors that are often
observed when amplified DNA fragments are first cloned
prior to sequence analysis. L. lactis strains studied were
selected for the capacity to ferment sucrose, a property often
linked to nisin production, since the genes involved in these
traits are physically linked and located on a conjugative
transposon (19). Twenty-six strains, many of which were
isolated from nondairy environments or as contaminants in
milk, were found to contain the structural gene for nisin
production, and in all cases a unique nis gene species was
found (Table 1). About half (14 of 26) of the tested strains
appeared to contain the nisZ gene sequence, indicating that
nisin Z producers are widespread. This is supported by the
finding that the nisZ gene is also present in L. lactis N8 (8a).
These data imply that the first strain in which the nisZ gene
was identified, NIZO 22186 (18), is not a rare mutant and
suggest that the nisA and nisZ genes have diverged and
subsequently have been disseminated in lactococcal strains.
It is likely that the latter process is effected by conjugation
since, analogous to nisin A production (19), nisin Z produc-
tion also appears to be encoded by a conjugative transposon
(designated TnS278 [20]). As a consequence, it is not possi-
ble to establish a parent-progeny relationship between the
nisA or nisZ genes, and hence both nisin A and nisin Z
should be considered wild-type nisins. The screening ap-
proach described here also allowed the detection of new
mutations. However, the sequence of all amplified nis genes
was identical to that first described for eithernisA (4) ornisZ
(18), indicating that the silent mutation at position 168 (18)
found in L. lactis 6F3 (14) is not widely present. Interest-
ingly, a double duplication of an octanucleotide sequence
was observed at the very end of the nisZ gene in strain
NCDO 2118, but it did not affect the coding sequence.
The screening approach based on direct sequencing of
PCR products that is used here in a search for natural nisin
variants allows reproducible and rapid analysis of existing
bacterial strains or new isolates. It is especially suitable for
gene fragments or small genes, such as those encoding the
production oflantibiotics or other bacteriocins. Complemen-
tary to protein engineering approaches, screening of natu-
rallyoccurring strains, includingnonproducers, may provide
further insight into the structure, function, and evolution of
nisin and other bacteriocins.
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